We imagine this change will upset many ThinkPad devotees, but given that we haven't seen a final production unit, we're not ready to passjudgementon the update.
The FDA has yet to passjudgementon the subject of substitutable or interchangeable biosimilars, but consensus indicates that such a status could be conferred ona biosimilar if it is supported with more extensive clinical testing.